IlluminOss Medical, Inc.
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From IlluminOss Medical, Inc.
Device center officials at the US agency focused on new approval pathways at RAPS Convergence 2020.
Scynexis highlights enrollment exceeding expectations in Phase III VVC trials; Daré prepares to enter Phase III to treat BV.
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
- Implantable Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.